FDC Limited has informed the Exchange regarding a press release dated August 25, 2020, titled "Launch of two variants of Favipiravir Drug (PiFLU and Favenza) meant to treat mild to moderate cases of Covid-19.".
Press Release Aug 25 2020
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from FDC
Later from FDC
- Press Release Oct 30 2020
- Press Release Nov 11 2020
- Press Release Feb 06 2021
- Press Release May 27 2021
- Press Release Jul 12 2021
Follow FDC into a list and get an email when it puts out news.
Follow FDC